TABLE 3.
Clinical characteristics | Multivariable analysis |
||
---|---|---|---|
HR | 95% CI | P-Value | |
Age at surgery, yearsa | 1.01 | 1.01–1.02 | < 0.001 |
Complicationsb | |||
Clavien ≥ 3 versus Clavien ≤ 2 | 1.22 | 1.00–1.50 | 0.047 |
Tumor size, cma | 1.11 | 1.05–1.17 | < 0.001 |
Tumor differentiation grade | |||
Poor vs. well/moderate | 1.24 | 1.06–1.45 | 0.006 |
Microscopic perineural invasion | |||
Yes versus no | 1.24 | 0.93–1.66 | 0.147 |
Positive lymph node ratio | |||
> 0.2 versus ≤ 0.2 | 1.49 | 1.26–1.76 | < 0.001 |
Resection margin status | |||
R1 versus R0 | 1.37 | 1.16–1.61 | < 0.001 |
Adjuvant therapy | |||
Adjuvant versus no adjuvant | 0.61 | 0.52–0.72 | < 0.001 |
Recurrence site | |||
Multiple-site versus no recurrence | 4.78 | 3.65–6.25 | < 0.001 |
Liver-only versus no recurrence | 5.75 | 4.39–7.55 | < 0.001 |
Local-only versus no recurrence | 2.46 | 1.86–3.24 | < 0.001 |
Lung-only versus no recurrence | 1.90 | 1.39–2.60 | < 0.001 |
Other versus no recurrence | 2.37 | 1.38–4.08 | 0.002 |
Significant values on multivariable analysis are shown in bold (P < 0.05)
HR hazard ratio, CI confidence interval
Continuous
According to the Clavien–Dindo classification